CN105969720B - 一种人类血管内皮细胞培养液及其培养方法 - Google Patents
一种人类血管内皮细胞培养液及其培养方法 Download PDFInfo
- Publication number
- CN105969720B CN105969720B CN201610614443.9A CN201610614443A CN105969720B CN 105969720 B CN105969720 B CN 105969720B CN 201610614443 A CN201610614443 A CN 201610614443A CN 105969720 B CN105969720 B CN 105969720B
- Authority
- CN
- China
- Prior art keywords
- cell
- culture
- vascular endothelial
- human vascular
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003511 endothelial effect Effects 0.000 title claims abstract description 31
- 230000002792 vascular Effects 0.000 title claims abstract description 24
- 239000012930 cell culture fluid Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title description 10
- 210000004027 cell Anatomy 0.000 claims abstract description 73
- 239000001963 growth medium Substances 0.000 claims abstract description 47
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 8
- 239000007640 basal medium Substances 0.000 claims abstract description 8
- 239000012894 fetal calf serum Substances 0.000 claims abstract description 8
- XGIKILRODBEJIL-UHFFFAOYSA-N 1-(ethylamino)ethanol Chemical compound CCNC(C)O XGIKILRODBEJIL-UHFFFAOYSA-N 0.000 claims abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims abstract description 7
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims abstract description 7
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims abstract description 7
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract description 7
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract description 7
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 7
- 229940126864 fibroblast growth factor Drugs 0.000 claims abstract description 7
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 7
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 7
- 239000011718 vitamin C Substances 0.000 claims abstract description 7
- 102000009016 Cholera Toxin Human genes 0.000 claims abstract description 6
- 108010049048 Cholera Toxin Proteins 0.000 claims abstract description 6
- SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 claims abstract description 6
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims abstract description 4
- 102000013275 Somatomedins Human genes 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 14
- 210000003606 umbilical vein Anatomy 0.000 claims description 10
- 230000001079 digestive effect Effects 0.000 claims description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 8
- 238000000338 in vitro Methods 0.000 claims description 8
- 230000010412 perfusion Effects 0.000 claims description 8
- 238000012136 culture method Methods 0.000 claims description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 102000029816 Collagenase Human genes 0.000 claims description 5
- 108060005980 Collagenase Proteins 0.000 claims description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- 229930182816 L-glutamine Natural products 0.000 claims description 5
- 229960002424 collagenase Drugs 0.000 claims description 5
- 229960002897 heparin Drugs 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 4
- 230000029087 digestion Effects 0.000 claims description 4
- 238000011010 flushing procedure Methods 0.000 claims description 4
- 229940049954 penicillin Drugs 0.000 claims description 4
- 210000003954 umbilical cord Anatomy 0.000 claims description 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims description 3
- 102000057593 human F8 Human genes 0.000 claims description 3
- 229940047431 recombinate Drugs 0.000 claims description 3
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 2
- 229960003942 amphotericin b Drugs 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 230000003373 anti-fouling effect Effects 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 210000002889 endothelial cell Anatomy 0.000 abstract description 15
- 210000003556 vascular endothelial cell Anatomy 0.000 abstract description 15
- 238000004113 cell culture Methods 0.000 abstract description 9
- 230000004663 cell proliferation Effects 0.000 abstract description 6
- 239000006143 cell culture medium Substances 0.000 abstract description 2
- 239000012531 culture fluid Substances 0.000 abstract description 2
- 238000005215 recombination Methods 0.000 abstract description 2
- 230000006798 recombination Effects 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 43
- 230000012010 growth Effects 0.000 description 11
- 210000004925 microvascular endothelial cell Anatomy 0.000 description 10
- 210000003462 vein Anatomy 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000003833 cell viability Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000005138 cryopreservation Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 108010019160 Pancreatin Proteins 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000002608 insulinlike Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100025947 Insulin-like growth factor II Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000011072 cell harvest Methods 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019628 coolness Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940068935 insulin-like growth factor 2 Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical group CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610614443.9A CN105969720B (zh) | 2016-07-29 | 2016-07-29 | 一种人类血管内皮细胞培养液及其培养方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610614443.9A CN105969720B (zh) | 2016-07-29 | 2016-07-29 | 一种人类血管内皮细胞培养液及其培养方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105969720A CN105969720A (zh) | 2016-09-28 |
CN105969720B true CN105969720B (zh) | 2019-11-05 |
Family
ID=56951209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610614443.9A Active CN105969720B (zh) | 2016-07-29 | 2016-07-29 | 一种人类血管内皮细胞培养液及其培养方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105969720B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106434530B (zh) * | 2016-11-16 | 2019-06-18 | 沈阳细胞治疗工程技术研发中心有限公司 | 一种内皮细胞培养液 |
CN106854661A (zh) * | 2016-12-26 | 2017-06-16 | 武汉波睿达生物科技有限公司 | 一种治疗***癌的car‑t细胞制剂的制备方法 |
CN106591221B (zh) * | 2017-01-16 | 2020-10-02 | 北京京蒙高科干细胞技术有限公司 | 人静脉内皮细胞的分离和体外扩增方法 |
CN107219359B (zh) * | 2017-06-04 | 2018-12-11 | 石强 | 一种功能性地检测抗体介导的器官排异的方法及其应用与试剂盒 |
CN109652361A (zh) * | 2017-10-12 | 2019-04-19 | 北京弘润天源基因生物技术有限公司 | 一种人脐静脉血管内皮细胞的原代分离培养及鉴定方法 |
CN109694843A (zh) * | 2017-10-20 | 2019-04-30 | 北京弘润天源基因生物技术有限公司 | 一种优化的人脐静脉血管内皮细胞获取方法 |
CN110923205A (zh) * | 2019-12-03 | 2020-03-27 | 南通大学 | 一种***内皮细胞培养基及其制备方法和用途 |
CN112680400A (zh) * | 2020-12-15 | 2021-04-20 | 五河县康爱生物科技有限公司 | 一种基于胎牛血清的细胞培养液的培养方法 |
CN112980776A (zh) * | 2021-03-23 | 2021-06-18 | 上海简巨医学生物工程有限公司 | 一种碳化铌纳米材料的应用及促进细胞增殖的细胞培养基 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103525753A (zh) * | 2013-09-23 | 2014-01-22 | 四川新生命干细胞科技股份有限公司 | 一种内皮克隆形成细胞的分离方法 |
CN104928230A (zh) * | 2015-06-05 | 2015-09-23 | 芜湖医诺生物技术有限公司 | 血管内皮细胞的培养方法 |
CN105754930A (zh) * | 2016-03-21 | 2016-07-13 | 杭州市萧山区中医院 | 一种毛囊干细胞诱导分化为血管内皮细胞的培养方法 |
-
2016
- 2016-07-29 CN CN201610614443.9A patent/CN105969720B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103525753A (zh) * | 2013-09-23 | 2014-01-22 | 四川新生命干细胞科技股份有限公司 | 一种内皮克隆形成细胞的分离方法 |
CN104928230A (zh) * | 2015-06-05 | 2015-09-23 | 芜湖医诺生物技术有限公司 | 血管内皮细胞的培养方法 |
CN105754930A (zh) * | 2016-03-21 | 2016-07-13 | 杭州市萧山区中医院 | 一种毛囊干细胞诱导分化为血管内皮细胞的培养方法 |
Non-Patent Citations (1)
Title |
---|
Anders H ægerstrand等.Serial cultivation of adult human endothelium from the great saphenous vein.《Journal of Vascular Surgery》.1992,第16卷(第2期),第280-285页. * |
Also Published As
Publication number | Publication date |
---|---|
CN105969720A (zh) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105969720B (zh) | 一种人类血管内皮细胞培养液及其培养方法 | |
US7122371B1 (en) | Modular cell culture bioreactor | |
CN107354129B (zh) | 一种自体皮肤来源的成纤维细胞培养方法 | |
US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
CN114317443B (zh) | 乳腺癌类器官培养液及其培养试剂组合和培养方法 | |
CN114292816B (zh) | 肺癌类器官培养液及其培养试剂组合和培养方法 | |
WO2010040262A1 (zh) | 分离动物胚胎间质性干细胞并提取其分泌物的方法 | |
CN101914495A (zh) | 用于体外大量扩增毛囊干细胞的培养方法 | |
CN110974944B (zh) | 间充质干细胞复合活性因子冻干粉及其制备方法和应用 | |
CN103966159B (zh) | 人胎盘亚全能干细胞及其干细胞库构建方法 | |
CN107164326B (zh) | 一种3D培养自体脂肪MSCs来源的神经前体细胞的方法 | |
CN104357387A (zh) | 一种从人脂肪组织中分离人脂肪干细胞的方法 | |
CN106119191A (zh) | 一种胎盘绒毛板间充质干细胞及临床化制备方法 | |
CN104726401A (zh) | 一种利用胎盘间充质干细胞提高脐血间充质干细胞培养成功率的方法 | |
CN107779429A (zh) | 一种人皮肤组织来源成纤维细胞快速分离培养方法 | |
CN106754650B (zh) | 一种骨髓来源的内皮祖细胞培养方法 | |
CN116836934B (zh) | 骨肉瘤类器官培养液、培养试剂组合及培养方法 | |
CN107513519B (zh) | 一种雪旺细胞的培养方法 | |
CN107674858B (zh) | 骨髓内皮祖细胞的分离培养基和分离方法 | |
CN109234230A (zh) | 一种皮肤间充质干细胞的原代分离方法 | |
CN108034634B (zh) | 一种从经血中分离宫内膜间充质干细胞的方法 | |
CN108660108A (zh) | 一种可增强脐带间充质干细胞免疫调节能力的方法 | |
CN113736737B (zh) | 一种原代胶质瘤相关成纤维细胞培养方法 | |
CN112941015B (zh) | 一种基于多能干细胞分化制备角质细胞的添加剂及方法 | |
CN105624115B (zh) | 一种诱导人脐带间充质干细胞分化为神经样细胞的培养基及其诱导方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240410 Address after: 201413 building 4, No. 1588, Xinyang Road, Lingang xinpian District, China (Shanghai) pilot Free Trade Zone, Fengxian District, Shanghai Patentee after: Shanghai Zhexian Pharmaceutical Technology Co.,Ltd. Country or region after: China Address before: Room 318, 3rd Floor, Building 7, No. 1180 Xingxian Road, Jiading District, Shanghai, 2018 Patentee before: SHANGHAI RUILU BIOTECHNOLOGY CO.,LTD. Country or region before: China |
|
TR01 | Transfer of patent right |